Liza L Ilag

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison
    Liza L Ilag
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Clin Ther 29:1254-70. 2007
  2. ncbi Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison
    Liza L Ilag
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Clin Ther 29:1254-70. 2007
  3. ncbi Improving diabetes processes of care in managed care
    Liza L Ilag
    Department of Internal Medicine, University of Michigan and the Michigan Diabetes Research and Training Center, Ann Arbor, Michigan, USA
    Diabetes Care 26:2722-7. 2003
  4. ncbi A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes
    William H Herman
    Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109 0354, USA
    Diabetes Care 28:1568-73. 2005
  5. ncbi Effects of blood glucose rate of changes on perceived mood and cognitive symptoms in insulin-treated type 2 diabetes
    Daniel J Cox
    Psychiatry and Neurobehavioral Sciences, University of Virginia Health Sciences Center, Charlottesville, VA, USA
    Diabetes Care 30:2001-2. 2007
  6. ncbi Addition of insulin to oral therapy in type 2 diabetes
    Liza L Ilag
    N Engl J Med 358:1197-8; author reply 1198. 2008

Detail Information

Publications6

  1. ncbi Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison
    Liza L Ilag
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Clin Ther 29:1254-70. 2007
    ..When glycemic goals are not achieved with the initial insulin regimen, a basal-bolus regimen is necessary...
  2. ncbi Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison
    Liza L Ilag
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Clin Ther 29:1254-70. 2007
    ..When glycemic goals are not achieved with the initial insulin regimen, a basal-bolus regimen is necessary...
  3. ncbi Improving diabetes processes of care in managed care
    Liza L Ilag
    Department of Internal Medicine, University of Michigan and the Michigan Diabetes Research and Training Center, Ann Arbor, Michigan, USA
    Diabetes Care 26:2722-7. 2003
    ..To evaluate the impact of systematic patient evaluation and patient and provider feedback on the processes and intermediate outcomes of diabetes care in Independent Practice Association model internal medicine practices...
  4. ncbi A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes
    William H Herman
    Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109 0354, USA
    Diabetes Care 28:1568-73. 2005
    ..To compare the efficacy and safety of continuous subcutaneous insulin infusion (CSII) and multiple daily injection (MDI) in older adults with insulin-treated type 2 diabetes and to assess treatment satisfaction and quality of life...
  5. ncbi Effects of blood glucose rate of changes on perceived mood and cognitive symptoms in insulin-treated type 2 diabetes
    Daniel J Cox
    Psychiatry and Neurobehavioral Sciences, University of Virginia Health Sciences Center, Charlottesville, VA, USA
    Diabetes Care 30:2001-2. 2007
  6. ncbi Addition of insulin to oral therapy in type 2 diabetes
    Liza L Ilag
    N Engl J Med 358:1197-8; author reply 1198. 2008